Authors
Latest:
Board Certification for Medical Science Liaisons: Implications for the Pharmaceutical IndustryMore than ever, confidence in objective, science-based data about therapeutics, such as the COVID-19 vaccine and other health care services, is a shared imperative across the pharmaceutical industry, health care communities, and the American public.
Latest:
Current Standards of Care in Platinum-Resistant Ovarian CancerFolate receptor α may be an important treatment target for ovarian tumors.
Latest:
Drug Shortages in Community Oncology: Ensuring Access to ChemotherapyPersistent chemotherapy drug shortages challenge oncology providers. American Oncology Network employs a drug shortage committee for organized shortage management that involves pharmacists and interdisciplinary stakeholders.
Latest:
New Curricular Framework Aims to Prepare, Inspire the Next Generation of Community Pharmacy LeadersThe framework includes 6 domains designed to immediately empower students in community pharmacies.
Latest:
The Pharmacy Model Is ChangingEmbracing artificial intelligence and other tools will be necessary to push the field forward.
Latest:
More Scrutiny Means Strict Regulation and OpportunityPharmacists can lead to the charge to innovate in both 503A and 503B settings, which are poised to change and grow.
Latest:
Assessing Quadruplet vs Triplet Regimens in Up-front Multiple Myeloma TreatmentResearch indicates quadruplet regimens may be a viable option for this disease.
Latest:
Navigating the Shadows: Understanding the Psychology and Pharmacology of Treating Postpartum DepressionA new treatment for postpartum depression has been developed with rapid onset, cutting down the time it has taken previous treatments to take effect by weeks or months.
Latest:
Understand the Effects of Topical Nasal Decongestants on Blood PressureBecause decongestants act by constricting blood vessels, their use can be problematic in individuals who have hypertension.
Latest:
Integration of Palliative Pharmacists to Elevate Oncologic CarePalliative pharmacists are invaluable assets of oncologic care.
Latest:
Fecal Microbiota, Live-jslm for the Prevention of Recurrent C difficile InfectionPharmacists play a key role in the use of live biotherapeutic products, including fecal microbiota, live-jslm for prevention of recurrent Clostridioides difficile (C difficile) infection.
Latest:
Sex and Gender Inequalities in Oncology Care and Research PersistStrategies to advance sex and gender equality nationally and globally in oncology have been initiated in recent years.
Latest:
All it Takes is a Conversation: Deprescribing Benzodiazepines in Older AdultsBenzodiazepines have proven effective in managing anxiety and insomnia, but they heighten risk of falls, cognitive impairment, functional decline, and mortality among older adults.
Latest:
Pharmacists Can Leverage Future Roles in Outcomes-Based Payment ModelsThe pharmacist integration model filled in gaps in care that appeared to positively affect MIPS and PCMH quality measures.
Latest:
Pharmacy Technicians Can Master Professional IntegrityAs technicians are increasingly involved in decision-making, they must exude confidence and advocate for themselves
Latest:
Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK InhibitorsThis article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
Latest:
During Summer Months, Counsel Patients on Preventing Lyme DiseaseEducation about prevention measures and early signs and symptoms of the condition are crucial
Latest:
Shaping the Future of Pharmacy: Trends to Watch at ASHP Midyear 2024Key trends shaping the future of health-system pharmacy include advanced medication management to address supply chain challenges, digital transformation to enhance pharmacy operations, and strategies for compliance with evolving regulations, all of which will be central topics at the ASHP Midyear 2024 meeting.
Latest:
Key Takeaways on FMTs in the Treatment of CDIExperts provide practice pearls for educating patients on and using FMTs for the management of CDI.
Latest:
Fecal Microbiota, Live-jslm for the Prevention of Recurrent C difficile InfectionPharmacists play a key role in the use of live biotherapeutic products, including fecal microbiota, live-jslm for prevention of recurrent Clostridioides difficile (C difficile) infection.
Latest:
Help Ensure Proper Medication Storage and DisposalEducation is key to providing information about proper techniques and bolstering patient safety.
Latest:
We Must Use the Vaccination Infrastructure We Already HavePharmacy and primary care are dramatically underallocated with COVID-19 doses compared with influenza efforts.
Latest:
Future Treatment Landscape of MZLClosing out their discussion on marginal zone lymphoma, the panel considers which future treatment strategies are most promising.
Latest:
Optimizing Infusion Chair Time for Oncology Trials: Follow-Up StudyThis study evaluated factors affecting the duration of the infusion appointment times for 392 clinical trial patients.
Latest:
Advice For Pharmacists Exploring Prescription Discount ProgramsExperts provide advice for community pharmacists wanting to explore options, such as Prescription Discount Programs, to help improve their patients’ outcomes.
Latest:
Future Pharmacy Experience: How Pharmacists Can Better Meet Patient NeedsPharmacies need to differentiate themselves through faster and cheaper care, while delivering health outcomes across the patient journey.
Latest:
Inhaler Techniques Can Become Sloppy Over TimePharmacists should counsel patients periodically to ensure correct usage for better disease and treatment management.
Latest:
Advances in Sickle Cell Disease: New Gene Therapies and Management StrategiesTwo groundbreaking cell-based gene therapies, exagamglogene autotemcel and lovotibeglogene autotemcel, were recently approved by the FDA for the treatment of sickle cell disease.
Latest:
Exploring the Landscape of Gene TherapyAn overview of how gene therapy has evolved since its inception, current applications, and emerging challenges.
Latest:
Don’t Worry, Be haPPI: Updates on PPI EquivalenciesDifferent guidelines have notable differences between equivalency dosing of proton pump inhibitors (PPI), resulting in confusion and a lack of confidence between medical professionals recommending one PPI over another.
